These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 19022679)
101. Synthesis and structure-activity relationships of 2-amino-1-aroylnaphthalene and 2-hydroxy-1-aroylnaphthalenes as potent antitubulin agents. Reddy GR; Kuo CC; Tan UK; Coumar MS; Chang CY; Chiang YK; Lai MJ; Yeh JY; Wu SY; Chang JY; Liou JP; Hsieh HP J Med Chem; 2008 Dec; 51(24):8163-7. PubMed ID: 19053773 [TBL] [Abstract][Full Text] [Related]
102. Semi-synthesis and anti-proliferative activity evaluation of novel analogues of Honokiol. Luo Y; Xu Y; Chen L; Hu J; Peng C; Xie D; Shi J; Huang W; Xu G; Peng M; Han J; Li R; Yang S; Wei Y Bioorg Med Chem Lett; 2009 Aug; 19(16):4702-5. PubMed ID: 19589678 [TBL] [Abstract][Full Text] [Related]
103. Synthesis, characterization and in vitro antiproliferative activities of new 13-cis-retinoyl ferrocene derivatives. Long B; Liang S; Xin D; Yang Y; Xiang J Eur J Med Chem; 2009 Jun; 44(6):2572-6. PubMed ID: 19231037 [TBL] [Abstract][Full Text] [Related]
104. A novel macrolide compound from Streptomyces bingchenggensis: fermentation, isolation, structure elucidation and biological properties. Xiang WS; Wang JD; Wang XJ; Zhang J J Antibiot (Tokyo); 2009 Apr; 62(4):229-31. PubMed ID: 19282877 [No Abstract] [Full Text] [Related]
105. Synthesis and in vitro and in vivo evaluation of a series of dihydroisocoumarin derivatives conjugated with fatty acids, alcohols, and amines as potential anticancer agents. Higgins CA; Delbederi Z; McGarel K; Mills T; McGrath O; Feutren-Burton S; Watters W; Armstrong P; Johnston PG; Waugh D; van den Berg H Bioconjug Chem; 2009 Sep; 20(9):1737-51. PubMed ID: 19708666 [TBL] [Abstract][Full Text] [Related]
106. CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy. Bao R; Lai CJ; Qu H; Wang D; Yin L; Zifcak B; Atoyan R; Wang J; Samson M; Forrester J; DellaRocca S; Xu GX; Tao X; Zhai HX; Cai X; Qian C Clin Cancer Res; 2009 Jun; 15(12):4046-57. PubMed ID: 19509149 [TBL] [Abstract][Full Text] [Related]
107. Structure-activity relationship studies of curcumin analogues. Fuchs JR; Pandit B; Bhasin D; Etter JP; Regan N; Abdelhamid D; Li C; Lin J; Li PK Bioorg Med Chem Lett; 2009 Apr; 19(7):2065-9. PubMed ID: 19249204 [TBL] [Abstract][Full Text] [Related]
108. A new synthetic approach to biaryls of the rhazinilam type. Application to synthesis of three novel phenylpyridine-carbamate analogues. Bonneau AL; Robert N; Hoarau C; Baudoin O; Marsais F Org Biomol Chem; 2007 Jan; 5(1):175-83. PubMed ID: 17164923 [TBL] [Abstract][Full Text] [Related]
109. Cytotoxic activity of Brazilian Cerrado plants used in traditional medicine against cancer cell lines. de Mesquita ML; de Paula JE; Pessoa C; de Moraes MO; Costa-Lotufo LV; Grougnet R; Michel S; Tillequin F; Espindola LS J Ethnopharmacol; 2009 Jun; 123(3):439-45. PubMed ID: 19501276 [TBL] [Abstract][Full Text] [Related]
110. Synthesis and antitumor activity of novel dithiocarbamate substituted chromones. Huang W; Ding Y; Miao Y; Liu MZ; Li Y; Yang GF Eur J Med Chem; 2009 Sep; 44(9):3687-96. PubMed ID: 19410339 [TBL] [Abstract][Full Text] [Related]
111. Total synthesis of marinomycins A-C and of their monomeric counterparts monomarinomycin A and iso-monomarinomycin A. Nicolaou KC; Nold AL; Milburn RR; Schindler CS; Cole KP; Yamaguchi J J Am Chem Soc; 2007 Feb; 129(6):1760-8. PubMed ID: 17249678 [TBL] [Abstract][Full Text] [Related]
112. Total synthesis and initial biological evaluation of new B-ring-modified bryostatin analogs. Wender PA; Horan JC; Verma VA Org Lett; 2006 Nov; 8(23):5299-302. PubMed ID: 17078702 [TBL] [Abstract][Full Text] [Related]
113. Synthesis and biological evaluation of distamycin analogues - new potential anticancer agents. Drozdowska D; Rusak M; Miltyk W; Midura-Nowaczek K Arch Pharm (Weinheim); 2009 Feb; 342(2):87-93. PubMed ID: 19173336 [TBL] [Abstract][Full Text] [Related]
114. Modular total synthesis of archazolid A and B. Menche D; Hassfeld J; Li J; Mayer K; Rudolph S J Org Chem; 2009 Oct; 74(19):7220-9. PubMed ID: 19739663 [TBL] [Abstract][Full Text] [Related]
115. Overcoming tumor drug resistance with C2-modified 10-deacetyl-7-propionyl cephalomannines: a QSAR study. Hansch C; Verma RP Mol Pharm; 2009; 6(3):849-60. PubMed ID: 19334723 [TBL] [Abstract][Full Text] [Related]
116. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents. Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657 [TBL] [Abstract][Full Text] [Related]
117. New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma. Deleuze-Masquefa C; Moarbess G; Khier S; David N; Gayraud-Paniagua S; Bressolle F; Pinguet F; Bonnet PA Eur J Med Chem; 2009 Sep; 44(9):3406-11. PubMed ID: 19278757 [TBL] [Abstract][Full Text] [Related]
118. Total synthesis of 2-hydroxytetracosanolide and 2-hydroxy-24-oxooctacosanolide by using an effective lactonization. Shiina I; Sasaki A; Kikuchi T; Fukui H Chem Asian J; 2008 Feb; 3(2):462-72. PubMed ID: 18203212 [TBL] [Abstract][Full Text] [Related]
119. A two-directional approach to a (-)-dictyostatin C11-C23 segment: development of a highly diastereoselective, kinetically-controlled Meerwein-Ponndorf-Verley reduction. Dilger AK; Gopalsamuthiram V; Burke SD J Am Chem Soc; 2007 Dec; 129(51):16273-7. PubMed ID: 18047348 [TBL] [Abstract][Full Text] [Related]